Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText.
Kick-your-searchterm to multiple Engines kick-your-query now !>
A dictionary by aggregated review articles of nephrology, medicine and the life sciences
Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

suck abstract from ncbi


10.1016/j.chom.2020.05.008

http://scihub22266oqcxt.onion/10.1016/j.chom.2020.05.008
suck pdf from google scholar
32464097!7255347!32464097
unlimited free pdf from europmc32464097    free
PDF from PMC    free
html from PMC    free

suck abstract from ncbi


Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534

Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534

Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534

Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534

Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534

Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
pmid32464097      Cell+Host+Microbe 2020 ; 27 (6): 870-878
Nephropedia Template TP

gab.com Text

Twit Text FOAVip

Twit Text #

English Wikipedia


  • Type I and Type III Interferons - Induction, Signaling, Evasion, and Application to Combat COVID-19 #MMPMID32464097
  • Park A; Iwasaki A
  • Cell Host Microbe 2020[Jun]; 27 (6): 870-878 PMID32464097show ga
  • Coronavirus disease 2019 (COVID-19) is a global pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Without approved antiviral therapeutics or vaccines to this ongoing global threat, type I and type III interferons (IFNs) are currently being evaluated for their efficacy. Both the role of IFNs and the use of recombinant IFNs in two related, highly pathogenic coronaviruses, SARS-CoV and MERS-CoV, have been controversial in terms of their protective effects in the host. In this review, we describe the recent progress in our understanding of both type I and type III IFN-mediated innate antiviral responses against human coronaviruses and discuss the potential use of IFNs as a treatment strategy for COVID-19.
  • |Animals[MESH]
  • |Antiviral Agents/pharmacology[MESH]
  • |Betacoronavirus/*physiology[MESH]
  • |COVID-19[MESH]
  • |Coronavirus Infections/drug therapy/*immunology/pathology/virology[MESH]
  • |Humans[MESH]
  • |Immune Evasion[MESH]
  • |Interferon Lambda[MESH]
  • |Interferon Type I/genetics/*immunology/pharmacology[MESH]
  • |Interferons/genetics/*immunology/pharmacology[MESH]
  • |Pandemics[MESH]
  • |Pneumonia, Viral/drug therapy/*immunology/pathology/virology[MESH]
  • |Recombinant Proteins/pharmacology[MESH]
  • |SARS-CoV-2[MESH]


  • DeepDyve
  • Pubget Overpricing
  • suck abstract from ncbi

    Linkout box